SEBI-Registered Investment Adviser | Fee-Only Portfolio Review
Portfolio Review & Analysis for Indian Investors
A serious second opinion on mutual funds, stocks and long-term portfolio structure.
Moneyvesta’s Portfolio Review & Analysis is an evidence-led investment portfolio review for Indian investors who want to know whether their mutual funds, direct stocks, ETFs, PMS exposure, NPS, cash and legacy holdings are efficiently built for long-term wealth creation.
The review examines portfolio structure, mutual fund overlap, regular-plan cost drag, direct equity quality, concentration risk, benchmark efficiency, tax friction, portfolio hygiene, action priorities and the portfolio’s actual journey versus a relevant benchmark. It is most useful for investors with meaningful portfolios, typically ₹20 lakh and above, where even small inefficiencies can become large rupee losses over time.
In one anonymised Moneyvesta Initial Portfolio Analysis, a ₹4.18 crore portfolio had 34 mutual fund schemes, 24 direct stocks, ₹1.82 crore in regular-plan mutual funds, elevated mid/small-cap and thematic exposure, and an estimated 1.1% visible annual drag, translating into an illustrative ₹32.8 lakh 5-year lost-gain estimate.
This is not a product pitch or a generic portfolio health check. The objective is to show what deserves to stay, what needs monitoring, what may be leaking compounding quality, and what requires a cleaner implementation sequence.
Portfolio Review Meaning
What Is a Portfolio Review?
A portfolio review is a structured diagnostic of everything you currently own: mutual funds, direct stocks, ETFs, cash and other investment exposures. It asks four practical questions.
Is the portfolio structure efficient for its size?
How much is it leaking through cost, overlap, tax friction or poor construction?
Is the underlying quality strong enough?
Is the portfolio behaving like a designed wealth system, or like an accumulation of past decisions?
Most Indian investors do not suffer from lack of market participation. They suffer from hidden inefficiency. A portfolio can be fully invested and still be poorly built. It can hold many mutual funds and still be highly overlapping. It can hold many stocks and still have weak business quality. It can show positive returns and still trail a sensible benchmark after cost and risk are considered.
A good portfolio review surfaces these issues with numbers, not opinions.
A portfolio can look diversified on paper and still be inefficient underneath.
Hidden Portfolio Inefficiency
Why Meaningful Portfolios Deserve a Deeper Review
Breadth is not the same as diversification.
Many investors reach ₹20 lakh, ₹50 lakh, ₹1 crore or more by adding products over time. A few funds are bought for tax saving. A few stocks are bought after strong performance. A few sector or thematic funds are added when a trend becomes popular. Old holdings remain because selling feels difficult.
This creates a portfolio that looks diversified on paper but may be inefficient underneath.
The real question is not how many investments you own. The real question is whether every meaningful holding is earning its place.
Moneyvesta Research Insights
Three Hidden Issues Inside Indian Portfolios
Hidden overlap, cost drag and quality dilution can be measured rather than guessed.
The following findings are based on Moneyvesta Research analysis of publicly available AMFI, SEBI and listed-company disclosures. They are shared to help investors understand why a serious portfolio review should go beyond past returns and product names.
Hidden Issue 1
Buying More Mutual Funds Does Not Automatically Diversify You
Multiple funds can still depend on the same underlying companies.
Many investors believe that holding 8, 10 or 15 equity mutual funds spreads risk. The underlying holdings often show a different story.
Moneyvesta Research analysed the latest disclosed equity holdings of five widely held flexi-cap funds in India: Parag Parikh, HDFC, Kotak, SBI and Aditya Birla Sun Life. On average, 72% of each fund’s equity portfolio overlaps with at least one of the other four. About 51% of each fund’s portfolio is in companies held by three or more of the five.
This means an investor who buys all five expecting five different portfolios may be buying a repeated version of similar underlying exposure.
The pattern is not limited to one category. In our active equity fund universe:
- HDFC Bank appears in 134 of 246 active equity mutual funds, or 54.5% of the universe.
- ICICI Bank appears in 53.7% of active equity funds.
- Reliance Industries appears in 46.7% of active equity funds.
- The top 20 most-held names account for 26.7% average exposure across active equity mutual funds.
- The top 50 most-held names account for 39.3% average exposure.
Hidden Issue 2
Regular Plans Can Quietly Cost More Than Investors Realise
A small annual TER difference can become a large rupee gap over time.
One of the most consistent issues in Indian mutual fund portfolios is regular-plan exposure. Many investors hold regular plans through a bank relationship manager, distributor, agent or platform, sometimes without realising the long-term cost impact.
The difference between a regular plan and a direct plan may look small each year. But when applied to a large corpus for 10, 15 or 20 years, the drag can become substantial.
20-Year Compounding Example
₹90 Lakh Approximate Value Gap
₹50 lakh at 12.00% grows to ~₹4.82 crore. At 10.85%, it grows to ~₹3.92 crore.
Values are illustrative and rounded for readability.
Assume a ₹50 lakh equity mutual fund corpus compounds for 20 years. If the direct plan compounds at 12% annually, the corpus grows to approximately ₹4.82 crore. If the same underlying investment earns 12% gross but loses 1.15 percentage points annually to regular-plan cost drag, the net return becomes 10.85%, and the corpus grows to approximately ₹3.92 crore.
| Corpus | Horizon | Assumed direct-plan return | Assumed regular-plan net return | Approximate value gap |
|---|---|---|---|---|
| ₹50 lakh | 10 years | 12.00% | 10.85% | ~₹15 lakh |
| ₹50 lakh | 20 years | 12.00% | 10.85% | ~₹90 lakh |
| ₹50 lakh | 25 years | 12.00% | 10.85% | ₹1.9 crore+ |
Hidden Issue 3
Stock Portfolios Often Mistake Stock Count for Quality
A 25-stock portfolio is not automatically a high-quality portfolio.
Direct equity investors often assume that holding 20 or 30 stocks makes the portfolio resilient. But stock count alone does not create quality.
A portfolio can hold many names and still have weak businesses, cyclical earnings, governance risk, high leverage, poor capital efficiency or positions too small to matter.
Moneyvesta Research applied a mild quality filter to 1,541 listed Indian companies with five years of financial disclosures. The filter required return on equity above 15% in each of the five most recent fiscal years and a rising profit base over the same broad window.
Only 89 companies cleared both filters simultaneously. That is 5.8% of the listed universe.
This does not mean the remaining companies are all bad businesses. It means that consistent quality is rarer than stock count makes it appear.
Six Diagnostic Pillars
What Moneyvesta Analyses in Your Portfolio
The framework is transparent enough to understand, while the exact scoring logic remains proprietary.
Moneyvesta’s portfolio review is built around six diagnostic pillars. The exact scoring weights, thresholds and calibration logic are proprietary, but the public framework is shared so that investors know what is being reviewed.
Returns vs Benchmark
Whether the portfolio is keeping pace with an appropriate reference, not just a headline index
Tests whether complexity is being justified by results
Mutual Fund Quality
Scheme count, AMC spread, category allocation, regular-plan exposure and overlap
Identifies whether the fund sleeve is efficient or cluttered
Direct Equity Quality
Business quality, return ratios, growth, leverage, valuation context and risk flags
Checks whether the stock book deserves the capital and monitoring burden
Concentration and Diversification
Largest exposure, top holdings, sector concentration, overlap-adjusted diversification
Separates genuine diversification from optical diversification
Cost, Tax and Friction
Regular-plan drag, churn, exit loads, tax friction and avoidable execution drag
Converts hidden leakage into visible rupee terms
Behaviour and Hygiene
Small-position clutter, hot-category additions, switching patterns and monitoring burden
Identifies whether the portfolio has been designed or accumulated reactively
Actual Portfolio Journey
Portfolio vs Benchmark: The Actual Journey
Returns should be reviewed at the total-portfolio level, not only holding by holding.
Many investors look at mutual funds, stocks and cash separately. That can miss the more important question: how did the combined portfolio behave as one wealth system?
Moneyvesta’s review reconstructs the portfolio journey across mutual funds, direct stocks and relevant cash flows, then compares it with an appropriate benchmark or blended reference.
Combined MF + Stocks Journey
Actual Journey vs BSE 500
A consolidated web-native view of how the reviewed portfolio moved against BSE 500 through the actual holding journey.
Early low-capital years are compressed for readability.
Anonymised Example
Sample Portfolio X-Ray: What We Found in a ₹4.18 Crore Portfolio
A portfolio can be fully invested and still be structurally inefficient.
The following example is anonymised and based on a recently reviewed portfolio. It is shown to illustrate the type of diagnostic output an investor can expect. The investor had a ₹4.18 crore portfolio across mutual funds, direct equity and cash. On the surface, the portfolio looked meaningfully invested and diversified. The deeper analysis showed avoidable structural inefficiency.
Portfolio Diagnostic Summary
| Component | What we found | Why it mattered |
|---|---|---|
| Total portfolio analysed | ₹4.18 crore | Large enough for small inefficiencies to become meaningful |
| Mutual funds | ₹2.64 crore across 34 schemes | Scheme count appeared materially above efficient levels |
| Direct equity | ₹1.39 crore across 24 stocks | Required review for duplication, quality and position sizing |
| Cash / liquid balance | ₹0.15 crore | Small stabilising allocation |
| Regular-plan exposure | ₹1.82 crore, or 69% of MF corpus | Created meaningful embedded cost drag |
| Mid and small-cap MF exposure | ₹0.98 crore, or 37% of MF corpus | Elevated category exposure requiring scrutiny |
| Thematic / sectoral exposure | ₹0.48 crore, or 18% of MF corpus | Above preferred levels for most investor profiles |
| Portfolio Health Score | 58/100 | Structurally weak diagnostic band |
| Visible annual drag | 1.1% | Estimated ₹32.8 lakh 5-year lost-gain impact |
Sources of Visible Drag
| Source of visible drag | Annualised drag estimate | Illustrative 5-year impact |
|---|---|---|
| Returns behind benchmark | 0.6% | ₹16.1 lakh |
| Regular-plan cost drag | 0.4% | ₹10.8 lakh |
| Trading and tax drag | 0.2% | ₹5.9 lakh |
| Total visible drag | 1.1% | ₹32.8 lakh |
Mutual Fund Portfolio Review
Is Your Mutual Fund Portfolio Creating Diversification or Just Complexity?
The issue is usually not one bad fund. The issue is the combination.
A mutual fund portfolio can become inefficient even when each individual fund looks respectable.
- Number of schemes and AMCs
- Direct versus regular plan exposure
- Expense ratio and cost drag
- Category allocation across large cap, flexi cap, mid cap, small cap, ELSS, thematic and debt funds
- Fund overlap and repeated underlying exposure
- Sector and market-cap concentration
- Benchmark relevance
- Role clarity of each scheme
- Hold, monitor or replacement priority
A strong mutual fund sleeve usually has a defined core, limited duplication, controlled cost, sensible category exposure and fewer low-conviction funds.
Stock Portfolio Analysis
A Stock Portfolio Should Be Judged by Business Quality, Not Just Stock Count
Owning 20 or 30 stocks does not automatically make a portfolio resilient.
A direct equity portfolio can still be fragile if too much capital sits in weaker businesses, cyclical companies, policy-sensitive sectors, highly leveraged balance sheets, expensive names, governance-risk situations or tiny positions that are not worth monitoring.
- Position size and concentration
- Business quality
- Return on equity and capital efficiency
- Growth consistency
- Balance sheet strength
- Debt, bad-loan or interest-safety risk where relevant
- Valuation context
- Promoter and governance risk markers
- Sector and cyclicality exposure
- Direct stock overlap with mutual funds
- Hold, monitor or clean-up priority
The exact thresholds and stock-level scoring logic are proprietary. The purpose of the public framework is to show what is being reviewed, not to publish the full decision engine.
Review Depth
Initial Portfolio Analysis vs Detailed Portfolio Analysis
Two levels of review, depending on the decision you need to make.
Initial Portfolio Analysis
The diagnostic stage. It helps answer whether your portfolio is broadly well built, whether it is too expensive or overlapping, whether hidden drags are reducing compounding, and whether a deeper holding-level review is needed.
Detailed Portfolio Analysis
The action stage. It converts diagnosis into holding-level interpretation and implementation priorities: what can stay, what needs monitoring, what should be cleaned up, and what should be phased responsibly.
| Area | Initial Portfolio Analysis | Detailed Portfolio Analysis |
|---|---|---|
| Primary purpose | Diagnose the portfolio | Convert diagnosis into action priorities |
| Level of detail | Portfolio-level and sleeve-level | Holding-level and implementation-level |
| Mutual funds | Structure, cost, overlap and category risk | Hold, monitor or replacement direction |
| Direct stocks | Quality, concentration and risk exposure | Hold, monitor or clean-up direction |
| Output | Scorecard, drag estimate, key weaknesses and next steps | Decision map, action buckets and sequencing plan |
| Best for | Knowing what is wrong and whether deeper review is needed | Knowing what to do and how to phase action responsibly |
Beyond Tracking Apps
How This Differs from Portfolio Trackers and Product-Led Reviews
A serious investor does not only need aggregation. They need diagnosis.
Most portfolio review tools are useful, but they are built for different purposes.
| Tool or service | What it usually does | Where Moneyvesta’s review goes deeper |
|---|---|---|
| Broker app analyser | Aggregates holdings, shows XIRR, allocation charts and basic portfolio views | We analyse overlap, cost drag, benchmark efficiency, direct equity quality and action priorities |
| Robo or model-portfolio platform | Compares holdings to a model portfolio or suggested allocation | We review what you currently own before deciding whether change is needed |
| Distributor or bank RM review | Often product-led and may be compensated through regular-plan trail commissions | Moneyvesta works on a fee-only advisory model and does not earn from AMC commissions |
| Moneyvesta Portfolio Review | Written diagnostic across structure, cost, quality, concentration, benchmark and behaviour | Designed to convert complexity into evidence, rupee impact and responsible next steps |
Review Process
How the Review Works
A structured diagnostic process without passwords, custody or product pressure.
Step 1: Share Your Holdings
You share your mutual fund consolidated account statement and direct equity holdings statement. We do not need broker passwords, trading access, OTPs or custody of funds.
Step 2: We Analyse Your Portfolio
The portfolio is reviewed across mutual fund structure, stock quality, overlap, cost drag, concentration, benchmark context, tax friction and portfolio hygiene.
Step 3: You Receive a Written Diagnostic
You receive a confidential written Initial Portfolio Analysis that explains the key findings, hidden drags, visible risks and priority next steps.
Step 4: Walkthrough With an Adviser
A senior adviser walks you through the report, answers your questions and explains whether a deeper holding-level review is required.
Who It Is For
Built for Investors Where Portfolio Mistakes Have Real Rupee Impact
The review is especially useful once the portfolio has become meaningful or complex.
Moneyvesta’s portfolio review is built for investors where the cost of getting structure wrong has become meaningful. This usually starts becoming important once the portfolio has crossed roughly ₹20 lakh, or when the portfolio has multiple mutual funds, direct stocks, legacy holdings or adviser-led product additions.
- Your investment portfolio is meaningful enough that cost drag, overlap or poor construction can have a real rupee impact.
- You hold several mutual funds and are unsure which ones are truly needed.
- You own both direct stocks and mutual funds.
- You have regular-plan mutual fund exposure and have never quantified the drag.
- You suspect your portfolio is over-diversified or cluttered.
- You are an HNI, senior professional, founder, business owner, doctor, bureaucrat or NRI with limited time to manage investments.
- You want a written diagnostic, not a product sales call.
Who Is Behind the Review
Reviewed Through a SEBI-Registered, Fee-Only Advisory Framework
The review is built by Moneyvesta’s research and advisory team, not by a product distributor.
Moneyvesta Capital Services Private Limited is a SEBI-Registered Investment Adviser. We operate on a fee-only advisory model and do not accept commission, trail, brokerage or revenue share from any mutual fund AMC, distributor, broker or insurer.
The firm was founded by Manasvi Garg, CFA, IIT Kanpur, MDI Gurgaon and CFA charterholder, with prior institutional research experience across equities and credit. The portfolio review framework is maintained by the Moneyvesta Research & Advisory Team.
The review uses publicly available regulatory and market disclosures, portfolio statements shared by the client, mutual fund scheme data, listed-company financial filings and Moneyvesta’s internal research engine. Every client-specific report is reviewed before delivery.
Request Your Review
Request Your Initial Portfolio Analysis
A structured review of your portfolio’s strengths, hidden drags and priority next steps.
If your portfolio has become meaningful and you have never had it reviewed by an adviser whose compensation does not depend on selling you a product, this may be one of the most useful financial diagnostics you can do. The review is especially suitable for investors with portfolios around ₹20 lakh and above, or portfolios that have become complex through multiple funds, stocks and legacy holdings.
You will receive a structured review of your current portfolio, including its visible strengths, hidden drags, overlap, cost issues, concentration risks and priority next steps.
Important Disclosure: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the Investment Adviser or provide any assurance of returns to investors.
The proprietary statistics on this page are derived from Moneyvesta Research analysis of publicly available AMFI, SEBI and listed-company disclosures as of February-March 2026. They are illustrative of market structure and portfolio-review methodology. They are not return forecasts and should not be relied on as such. Client-specific advice is provided only under applicable engagement terms.